InsidersTradesSigma
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the complete record of transactions filed by Schall Thomas J., Chairman & CEO. Insider active across 2 companies, notably ChemoCentryx, Inc.. Aggregated, 8 disclosures have been recorded. Breakdown: 4 buys · 0 sell. Total volume traded: €201k. History available since 1 December 2021. The latest transaction was filed on 15 January 2026 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations
Schall Thomas J. is Président-Directeur Général. He has 8 filings in total, and across the recent filings available, the transactions are acquisitions, with EUR 201060 of buys and EUR 0 of sells between 2021-12-03 and 2026-01-20. His listed companies are Immuneering Corp, where he is Director, and ChemoCentryx, Inc., where he is President and CEO.